title: Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis.
abstract: Since the Chlamydia pneumoniae (C. pneumoniae)-specific antibody was shown to be associated with acute myocardial infarction and chronic coronary heart disease, the role of C. pneumoniae in the etiology of cardiovascular disease has been studied by a number of groups. We investigated the association between the C. pneumoniae-specific antibody, measured by microimmunofluorescence, risk factors for cardiovascular disease, and atherosclerosis in a randomly selected urban population. Overall, immunoglobulin-G (IgG) seroprevalence to C. pneumoniae in this sample of 1,034 subjects was 58%, whereas IgA seroprevalence was 32%. There was a decline in seropositivity with age for IgG but not IgA. Men were more likely than women to be IgG (66% vs 51%, chi-square p = 0.001) and IgA seropositive (36% vs 28%, chi-square p = 0.005). Current smokers had higher IgA seropositivity than nonsmokers (43% vs 30%). Those patients with a family history of cerebrovascular disease were more likely to have IgG antibody than those without (75% vs 57%, chi-square p= 0.007). Neither IgG nor IgA seropositivity was associated with the standard risk factors of hypertension, hyperlipidemia, or family history of ischemic heart disease, nor was seropositivity associated with carotid intima medial thickening (IMT) or atherosclerotic plaque as measured by carotid B-mode ultrasound. There was no difference between those participants who were IgG or IgA seropositive and seronegative in measurements of mean IMT, prevalence of abnormal IMT, and percentage with atherosclerotic plaque. In conclusion, although C. pneumoniae was associated with several risk factors for cardiovascular disease in a large cross-sectional population, we found no independent association between seroprevalence to C. pneumoniae and carotid atherosclerosis as measured by carotid IMT.
authors.affiliation: Department of Public Health, The University of Western Australia, Nedlands. katie@dph.uwa.edu.au
authors.forename: K A
authors.initials: KA
authors.lastname: Coles
authors.forename: A J
authors.initials: AJ
authors.lastname: Plant
authors.forename: T V
authors.initials: TV
authors.lastname: Riley
authors.forename: D W
authors.initials: DW
authors.lastname: Smith
authors.forename: B M
authors.initials: BM
authors.lastname: McQuillan
authors.forename: P L
authors.initials: PL
authors.lastname: Thompson
mesh_terms: D000328:Adult; D000368:Aged; D000907:Antibodies, Bacterial / Q000097:blood*; D001161:Arteriosclerosis / Q000000981:diagnostic imaging / Q000276:immunology* / Q000382:microbiology; D002340:Carotid Artery Diseases / Q000000981:diagnostic imaging / Q000276:immunology* / Q000382:microbiology; D016009:Chi-Square Distribution; D016993:Chlamydophila pneumoniae / Q000276:immunology*; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000097:blood*; D007074:Immunoglobulin G / Q000097:blood*; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D011795:Surveys and Questionnaires; D014463:Ultrasonography; D014505:Urban Population; D014904:Western Australia / Q000453:epidemiology
chemical_list: D000907:Antibodies, Bacterial; D007070:Immunoglobulin A; D007074:Immunoglobulin G